Evidence map›Paper›PMID 33193179›Full record

ArticleFrontiers in microbiology2020

Insights in the Antimicrobial Potential of the Natural Nisin Variant Nisin H.

Jens Reiners, Marcel Lagedroste, Julia Gottstein, Emmanuel T Adeniyi, Rainer Kalscheuer, Gereon Poschmann, Kai Stühler, Sander H J Smits, Lutz Schmitt

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. The extracellular domain ofFrontiers in microbiology · 2025
    Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Jens ReinersInstitute of Biochemistry, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
Marcel LagedrosteInstitute of Biochemistry, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
Julia GottsteinInstitute of Biochemistry, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
Emmanuel T AdeniyiInstitute of Pharmaceutical Biology and Biotechnology, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
Rainer KalscheuerInstitute of Pharmaceutical Biology and Biotechnology, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
Gereon PoschmannInstitute for Molecular Medicine, Medical Faculty, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
Kai StühlerInstitute for Molecular Medicine, Medical Faculty, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
Sander H J SmitsInstitute of Biochemistry, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
Lutz SchmittInstitute of Biochemistry, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
Heinrich Heine University Düsseldorf · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lantibiotics are a growing class of antimicrobial peptides, which possess antimicrobial activity against mainly Gram-positive bacteria including the highly resistant strains such as methicillin-resistant

Indexed as

antimicrobial activitylantibioticsMS analysisnisinnisin H

Identifiers

PMID33193179
PMCPMC7606277
OpenAlexW3094508843

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.